India Peritoneal Dialysis Market 2024–2033

Reports Description

India Peritoneal Dialysis Market was valued at USD 52.6 Million in 2024 and is expected to reach USD 145.2 Million by 2033, at a CAGR of 9.1% during the forecast period 2024 – 2033.

Peritoneal dialysis (PD) is a way of removing waste and surplus fluids from the body when the kidneys are unable to do so properly. It is a type of dialysis that uses the peritoneum, a membrane that lines the abdominal cavity, as a natural filter.

India Peritoneal Dialysis Market: Growth Factors

Increasing prevalence of end-stage renal disease

The increasing prevalence of end-stage renal disease (ESRD) in India has been a significant driver for the growth of the peritoneal dialysis market in the country. With a rising incidence of conditions such as diabetes and hypertension, which are leading causes of ESRD, the demand for effective renal replacement therapies has surged.

Peritoneal dialysis offers several advantages over haemodialysis, including lower cost, greater flexibility, and the potential for home-based treatment, which is particularly appealing in a country like India with its vast geographic spread and diverse population.

Furthermore, peritoneal dialysis does not require highly specialized infrastructure and can be administered with relatively simple equipment, making it more accessible, especially in rural and underserved areas where access to healthcare facilities may be limited.

As awareness about the benefits of peritoneal dialysis grows among both patients and healthcare providers, coupled with government initiatives to improve renal care infrastructure and increase access to dialysis services, the market for peritoneal dialysis is expected to continue expanding rapidly in India.

The approximate prevalence of CKD is 800 per million population (pmp), and the incidence of end-stage renal disease (ESRD) is 150-200 pmp.

Increasing demand for home dialysis treatment

The growing demand for home dialysis treatment is a significant driver propelling the expansion of the peritoneal dialysis market in India. Home dialysis, particularly peritoneal dialysis, offers numerous advantages over traditional centre-based haemodialysis, making it an appealing option for patients and healthcare providers alike.

Peritoneal dialysis allows patients to undergo treatment in the comfort of their own homes, offering greater flexibility, convenience, and independence compared to frequent visits to dialysis centres.

With India’s vast geographical expanse and varied healthcare infrastructure, home-based treatments alleviate the burden of travel and reduce the strain on already overstretched healthcare facilities, particularly in rural and remote areas where access to specialized medical care may be limited.

Moreover, the COVID-19 pandemic has underscored the importance of minimizing exposure to crowded healthcare settings, further fuelling the shift towards home-based dialysis solutions.

Additionally, peritoneal dialysis typically requires less complex equipment and infrastructure compared to haemodialysis, making it a more cost-effective option for both patients and healthcare systems in resource-constrained settings like India.

As awareness of the benefits of home dialysis grows and technology advances to improve the ease and safety of self-administered treatments, the market for peritoneal dialysis in India is poised for continued expansion to meet the evolving needs of patients and healthcare providers.

India Peritoneal Dialysis Market: Restraints

High cost

The high cost presents a significant hurdle to the growth of the peritoneal dialysis (PD) market in India. The expenses associated with PD can be prohibitive for many patients in India, where a considerable portion of the population faces financial constraints.

The upfront costs of PD equipment, including catheters, bags, and dialysis solutions, coupled with ongoing expenses for supplies and medical consultations, pose a substantial financial burden for patients and their families.

Moreover, the lack of widespread health insurance coverage for dialysis treatment exacerbates the affordability issue, as patients are often required to bear the expenses out of pocket. The high cost of PD not only limits access to treatment but also contributes to suboptimal patient outcomes, as some individuals may forego or delay therapy due to financial constraints, leading to complications and worsening health conditions.

Addressing the cost barriers through initiatives such as government subsidies, insurance coverage expansion, and promoting the use of cost-effective PD modalities could help improve access to this vital treatment option for kidney disease patients in India.

India Peritoneal Dialysis Market: Opportunities

Increasing healthcare expenditure

Increasing healthcare expenditure in India is a pivotal driver propelling growth in the peritoneal dialysis market. As healthcare spending rises, more resources become available for advanced medical treatments, including renal replacement therapies like peritoneal dialysis.

Moreover, increased healthcare expenditure fosters technological advancements and innovation in medical devices and equipment, leading to the development of more efficient and cost-effective peritoneal dialysis solutions tailored to the Indian market’s needs.

Additionally, rising healthcare expenditure facilitates greater awareness and education about chronic kidney disease and its management options, including peritoneal dialysis, among both healthcare professionals and the general population, further driving market growth by boosting demand for these services.

Consequently, the synergy between escalating healthcare spending and the demand for effective renal care solutions like peritoneal dialysis underscores its substantial growth potential within the Indian healthcare landscape.

According to the Centre for Budget and Governance Accountability’s (CBGA) analysis of the Union Budget, the overall allocation1 in 2024-25 for the health sector stood at USD 100 million, which is a marginal increase of 2.6% from the previous budget estimates (BE) and a 14.2% increase from the revised estimates.

India Peritoneal Dialysis Market: Segmentation Analysis

India Peritoneal Dialysis market is segmented by type, product, and region.  Based on type, the market is classified into Continuous Ambulatory Peritoneal Dialysis (CAPD), and  Automated Peritoneal Dialysis (APD).

Continuous Ambulatory Peritoneal Dialysis dominated the market in 2023 with a market share of 70.3% and is expected to keep its dominance during the forecast period 2024-2033.  Continuous Ambulatory Peritoneal Dialysis (CAPD) has been a significant driver in shaping the peritoneal dialysis market in India.

CAPD offers several advantages over traditional haemodialysis, making it a preferred choice for many patients. Its simplicity and flexibility allow patients to perform dialysis at home without the need for expensive machinery or frequent visits to healthcare facilities.

Moreover, CAPD offers patients greater independence and improved quality of life by allowing them to maintain their daily routines and avoid the disruption of frequent hospital visits. Additionally, CAPD has a lower risk of complications such as infection and vascular access-related issues compared to haemodialysis, further contributing to its growing popularity.

As awareness about the benefits of CAPD increases and healthcare providers expand their peritoneal dialysis programs, the demand for CAPD is expected to continue driving growth in the Indian peritoneal dialysis market, providing more patients with access to effective renal replacement therapy.

Based on product, the market is classified into Devices (Cyclers/Machines), PD Solutions/Fluids, PD Sets, and Catheters. PD Solutions/Fluids dominated the market in 2023 with a market share of 49.9% and is expected to keep its dominance during the forecast period 2024-2033.

PD solutions/fluids play a crucial role in driving the peritoneal dialysis (PD) market in India by providing an effective and convenient treatment option for patients with end-stage renal disease (ESRD). These solutions, which are infused into the peritoneal cavity through a catheter, facilitate the removal of waste products and excess fluid from the body, mimicking the function of healthy kidneys.

In India, where access to healthcare services can be challenging, PD offers several advantages, including lower cost, greater flexibility, and the ability for patients to undergo treatment at home, reducing the need for frequent hospital visits.

The availability of a variety of PD solutions tailored to different patient needs further enhances the appeal of this therapy. As the prevalence of ESRD continues to rise in India due to factors such as an aging population and increasing incidence of diabetes and hypertension, the demand for PD solutions is expected to grow significantly.

Moreover, ongoing advancements in PD technology and the introduction of innovative formulations with improved biocompatibility and efficacy are likely to further propel market growth, making PD an increasingly vital component of renal care in India.

Report Scope

India Peritoneal Dialysis Market: Regional Analysis

By region, the Peritoneal Dialysis market is segmented into East India, West India, North India and South India. West India dominated the India Peritoneal Dialysis market in 2023 with a market share of 41.4% and is expected to keep its dominance during the forecast period 2024-2033.

The West India region plays a pivotal role in propelling the peritoneal dialysis market within India due to several key factors. Firstly, the region is characterized by a high prevalence of chronic kidney disease (CKD), a primary indication for peritoneal dialysis, attributed to lifestyle factors, genetic predispositions, and a rising geriatric population.

Furthermore, West India encompasses major metropolitan areas such as Mumbai, Pune, and Ahmedabad, which serve as hubs for healthcare infrastructure, including specialized nephrology centers and dialysis facilities.

Additionally, the West Indian region is home to a burgeoning medical tourism industry, drawing patients from across the country and abroad for affordable yet high-quality healthcare services, including peritoneal dialysis.

Consequently, the concentration of healthcare resources, coupled with a growing patient population and medical tourism influx, positions West India as a driving force in shaping the landscape and growth trajectory of the peritoneal dialysis market in India.

India Peritoneal Dialysis Market: Recent Developments

• In October 2019, The Indian Union Ministry of Health and Family Welfare announced the establishment of a new set of guidelines for peritoneal dialysis services under the Pradhan Mantri National Dialysis Programme.

• In May 2019, The Indian Union Ministry of Health and Family Welfare announced the plans to offer peritoneal dialysis facilities for patients suffering from kidney ailments under the Pradhan Mantri National Dialysis Programme (PMNDP).

List of the prominent players in the India Peritoneal Dialysis Market:

• Fresenius Medical Care
• Baxter International Inc.
• Braun Melsungen AG
• Medtronic plc
• DaVita Inc.
• Nipro Corporation
• Terumo Corporation
• Cook Medical Inc.
• Allmed Medical Care Holdings Limited
• CardioMed Supplies Inc.
• Covidien
• NxStage Medical Inc.
• Poly Medicure Limited
• Asahi Kasei Corporation
• Bio-Rad Laboratories Inc.
• Cantel Medical Corporation
• Hospira Inc.
• Rockwell Medical
• Stryker Corporation
• Toray Medical Co. Ltd.
• Others

These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.

The India Peritoneal Dialysis Market is segmented as follows:

By Type

• Hemodialysis
  • Conventional
  • Short Daily Hemodialysis
  • Nocturnal Hemodialysis
• Peritoneal Dialysis
  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • Automated Peritoneal Dialysis (APD)

By Product

• Device
  • Machine
  • Dialyzers
  • Water Treatment System
  • Others
• Consumables
  • Bloodlines
  • Concentrates
  • Catheters
  • Others
• Service

By End-use

• Home-based
• Hospital-based